Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Leases: 2020-2021

Historic Leases for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $28.4 million.

  • Black Diamond Therapeutics' Leases rose 235.16% to $28.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $28.4 million, marking a year-over-year increase of 235.16%. This contributed to the annual value of $8.4 million for FY2020, which is N/A change from last year.
  • Per Black Diamond Therapeutics' latest filing, its Leases stood at $28.4 million for Q3 2021, which was up 115.20% from $13.2 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Leases registered a high of $28.4 million during Q3 2021, and its lowest value of $382,000 during Q2 2020.
  • For the 2-year period, Black Diamond Therapeutics' Leases averaged around $10.4 million, with its median value being $8.5 million (2020).
  • Data for Black Diamond Therapeutics' Leases shows a peak YoY soared of 3,350.52% (in 2021) over the last 5 years.
  • Black Diamond Therapeutics' Leases (Quarterly) stood at $8.4 million in 2020, then soared by 235.16% to $28.4 million in 2021.
  • Its Leases stands at $28.4 million for Q3 2021, versus $13.2 million for Q2 2021 and $13.8 million for Q1 2021.